Our study conducted by Wang et al. observed that tomato extract inhibited NASH-promoted hepatocarcinogenesis through reduction in CYP2E1 expression, whereas the chemopreventative effects of lycopene were associated with the induction of Nrf2 and HO-1 [139]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.